Pierre-Luc Etienne

ORCID: 0000-0002-7549-9892

2

h-index

3

Publications

2,292

Citations

Publications

2 shown

Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients

Michel Ducreux , Emmanuel Mitry , Mahmoud Ould-Kaci +10 more

2004 Annals of Oncology 114 citations

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

Thierry Conroy , Jean-François Bosset , Pierre-Luc Etienne +54 more

2021 The Lancet Oncology 1089 citations

Frequent Co-Authors

Michel Ducreux

Institut Gustave Roussy

Emmanuel Mitry

Hôpital Ambroise-Paré

Mahmoud Ould-Kaci

Valérie Boige

Institut Gustave Roussy

J. F. Seitz

Institut Paoli-Calmettes

R. Bugat

Centre Antoine Lacassagne

Researcher Info

h-index: 2
Publications: 3
Citations: 2,292

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-7549-9892

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.